Pergamum Is A Biopharmaceutical Company That Specializes In Therapeutic Peptides With A Particular Focus On Topical Application In Dermatology And Wound Healingthe Development Pipeline At Present Includes Three Programs In Clinical Developmentto Treat Skin Infectionsatopic Dermatitis As Well As To Prevent Formation Of Post Surgical Adhesions Following Flexor Tendon Repair Surgery Andas An Extension Indicationfollowing Orthopedic Surgeryanother Program Is In Preclinical Developmentto Promote Healing Of Hard To Heal Woundspergamum Estimates Its Products To Have A Combined Peak Sales Potential Of Greater Than A 1 Billion Pergamum Recently Merged And Integrated Three Innovative Biotech Start Upsdermagenpharmasurgics And Lipopeptideinto One Operational Company To Capture On Synergiespergamum Has Built A Business Modelwhich Combines Leading Edge Program Management And Business Developmentthis Approach Will Ultimately Increase The Success Rate In Pergamum S Drug Development Initiatives And Minimize Time To Marketin Additionthis Model Enables Pergamum To Pursue Multiple Exitand Partnering Opportunitiesand Enhance Return On Venture Financed Biotech Investments
No conferences found for this company.
| Company Name | Lipopeptide Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
